LinkOPH

Valeant Pharmaceuticals International announced in a press release that J. Michael Pearson has returned as its CEO after taking medical leave of absence for severe pneumonia and other complications.Howard B. Schiller, who had been named Valeant’s interim CEO, will continue as a member of Valeant’s board of directors while transitioning out of his current duties, according to the release. Robert A. Ingram has been named chairman of the board, with Valeant separating the roles of chairman and CEO, the release reported.

Read more →

ATLANTA – An Alcon executive explained the company’s plans to separate its medical device and pharmaceutical businesses, during a company-sponsored press conference here at SECO.Richard E. Weisbarth, OD, FAAO, Alcon vice president of professional affairs, detailed the rationale behind the changes that were announced in January.

Read more →

At OSN New York, Nicole R. Fram , MD, talks about the challenges of malpositioned IOLs in the setting of corneal diseases.

Read more →

ATHENS, Greece — A study conducted in Schleswig Holstein, the northernmost federal state of Germany, showed lower standards of care for cataract patients in rural areas compared with urban regions, mainly related to poor and often delayed access to ophthalmological services. “In this part of Germany there are only a few cities surrounded by countryside, where medical services are structurally weaker,” Tim Herbst, MBA, said.

Read more →

Topography-guided PRK followed by corneal collagen cross-linking yielded a significantly greater improvement in vision than cross-linking alone in eyes with progressive keratoconus, a study found.Both procedures yielded similarly stable postoperative o…

Read more →